| First Author | Jiang Y | Year | 2023 |
| Journal | Sci Adv | Volume | 9 |
| Issue | 19 | Pages | eadf3775 |
| PubMed ID | 37163602 | Mgi Jnum | J:355374 |
| Mgi Id | MGI:7481735 | Doi | 10.1126/sciadv.adf3775 |
| Citation | Jiang Y, et al. (2023) Single-domain antibody-based noninvasive in vivo imaging of alpha-synuclein or tau pathology. Sci Adv 9(19):eadf3775 |
| abstractText | Intracellular deposition of alpha-synuclein and tau are hallmarks of synucleinopathies and tauopathies, respectively. Recently, several dye-based imaging probes with selectivity for tau aggregates have been developed, but suitable imaging biomarkers for synucleinopathies are still unavailable. Detection of both of these aggregates early in the disease process may allow for prophylactic therapies before functional impairments have manifested, highlighting the importance of developing specific imaging probes for these lesions. In contrast to the beta sheet dyes, single-domain antibodies, found in camelids and a few other species, are highly specific, and their small size allows better brain entry and distribution than whole antibodies. Here, we have developed such imaging ligands via phage display libraries derived from llamas immunized with alpha-synuclein and tau preparations, respectively. These probes allow noninvasive and specific in vivo imaging of alpha-synuclein versus tau pathology in mice, with the brain signal correlating strongly with lesion burden. These small antibody derivatives have great potential for in vivo diagnosis of these diseases. |
